Astrazeneca's U.S. trial remains on hold pending FDA review
![Laboratory technicians handle capped vials as part of filling and packaging tests for the large-scale production and supply of the Covid-19 vaccine candidate AZD1222. | Foto: Vincenzo Pinto/AFP/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12417204.ece/ALTERNATES/schema-16_9/20200911-174828-1-1920x1080we.jpg)
Astrazeneca Covid-19 vaccine study remains paused in the U.S. pending a regulatory review of an incident in which a U.K. study participant became ill, federal officials said.
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.